Tag Archives: Marketing

Marketing: A Digital Disconnect

By Julian Upton | Published: October 6, 2010
Peter Houston is concerned that pharma is taking too long getting to grips with digital marketing. I was at the 2nd European DigiPharm conference in London last week. I didn’t manage the whole two days, but what I did see left me a little concerned that pharma is still struggling with digital marketing. This is not a [...]
Posted in E-Media, Europe, Global, Guest Blog, Technology, social media | Also tagged , , | 1 Comment

Big Pharma Reps Still Competing with Local Players in Emerging Markets

By Reid Paul | Published: September 15, 2010
Although pharma is an increasingly global marketplace, the relative rankings of companies are becoming more localized — with significant variations — according to a new Cegedim survey of physician attitudes towards reps in the major western markets and Brazil, India, Russia, and China. According to the International Rep Quality survey, physicians tend to favor domestic [...]
Posted in Emerging Markets, Europe, Guest Blog, Marketing, Sales | Also tagged , , , , , | Leave a comment

Baxter Receives Third FDA Warning for Misleading Promotional Material

By Julian Upton | Published: September 1, 2010
FDA issued a warning letter to Baxter International for making “misleading efficacy claims” about its lung drug Araplast NP, which is contraindicated in individuals with selective IgA deficiencies and prescribed to patients who are at increased risk of emphysema. FDA’s letter, dated Aug. 3, takes issue with claims in a brochure aimed at physicians that [...]
Posted in FDA | Also tagged , , , , | Leave a comment

GSK Scores High in Market Access

By George Koroneos | Published: June 23, 2010
GlaxoSmithKline ranked number one in a study of pharmaceutical companies offering access to medicines to emerging and developing nations, proving that the UK drug giant has a far stronger grasp on new markets than its US and Japanese counterparts. The study ranks 20 companies based on significant criteria including pricing, patents and intellectual properties, capacity enhancement, [...]
Posted in Emerging Markets, Strategy | Also tagged , , , , , , | Leave a comment

New FDA Campaign Targets Detailing, Trade Shows

By Jill Wechsler | Published: May 19, 2010
In addition to sending out more warning letters and stepping up enforcement activity, the Food and Drug Administration wants health professionals to do more to police drug marketing and advertising. The agency’s “Bad Ad” program urges doctors and other health professionals to report any false or misleading ads or inappropriate marketing pitches. Depending on one’s [...]
Posted in FDA, News, Regulatory | Also tagged , , , , , | Leave a comment